A detailed history of Gps Wealth Strategies Group, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Gps Wealth Strategies Group, LLC holds 393 shares of EXAS stock, worth $23,725. This represents 0.0% of its overall portfolio holdings.

Number of Shares
393
Previous 273 43.96%
Holding current value
$23,725
Previous $11,000 136.36%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$42.43 - $70.83 $5,091 - $8,499
120 Added 43.96%
393 $26,000
Q2 2024

Jul 16, 2024

BUY
$41.33 - $74.26 $11,283 - $20,272
273 New
273 $11,000
Q3 2021

Oct 20, 2021

SELL
$90.24 - $124.05 $8,121 - $11,164
-90 Closed
0 $0
Q2 2021

Jul 19, 2021

SELL
$93.66 - $139.27 $4,214 - $6,267
-45 Reduced 33.33%
90 $11,000
Q1 2021

Apr 15, 2021

BUY
$116.57 - $155.01 $15,736 - $20,926
135 New
135 $17,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.7B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Gps Wealth Strategies Group, LLC Portfolio

Follow Gps Wealth Strategies Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gps Wealth Strategies Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gps Wealth Strategies Group, LLC with notifications on news.